Brazil: India’s Bharat Biotech signs deal to provide 20m doses of Covaxin
By Fatima Sule [NAN]
Indian biotechnology company Bharat Biotech on Friday announced that it has signed an agreement with Brazil to supply 20 million doses of India’s first domestically-produced COVID-19 vaccine Covaxin to the country.
The Indian vaccine is built on the inactivated virus platform with a dosing regimen of two shots per patient 28 days apart.
“Bharat Biotech International Limited today confirmed that the company has signed an agreement with Brazil for supply of 20 million doses of COVAXIN.
“The company is delighted to partner with Brazil in its battle against COVID-19 and aid its immunisation programme against the virus.
“It has signed an agreement for delivery of COVAXIN during Q2 and Q3 2021,” the company said in a statement.
Brazil’s national mass vaccination campaign started on Jan. 18.
The county is currently using the vaccines by Sinovac and AstraZeneca.
Earlier in the week, Brazil approved the use of the Pfizer vaccine as well.
To date, the Brazilian vaccination campaign covered 3.0 per cent of the population — approaching 7.8 million people — with at least one dose.
Around 0.8 per cent of the population have received both doses. (Sputnik/NAN)
© Copyright 2020 ElombahNews.
DISCLAIMER : Opinion articles are solely the responsibility of the author and does not necessarily reflect the views of the publishers of ElombahNews!
Would you like to be receiving ALL ElombahNews links ‘On The Go’ on WhatsApp Or Telegram? If yes, join us here on WhatsApp or Telegram, or provide us your Telephone number via email@example.com or sms/inbox +2349050382526 and you are good to go!
DOWNLOAD ElombahNews mobile app here
Send eyewitness accounts/ reports/ articles to firstname.lastname@example.org; follow us on twitter @ElombahNews; like our Facebook page ElombahNews